Evolving Standards of Care in EGFR+: Evaluating the Shift from TKIs to CombinationsKey Takeaways: For nearly a decade, the management of advanced EGFR-mutant non-small cell lung cancer (NSCLC) has been dominated by the success...reactionscomments
Beyond EGFR+: The Clinical Relevance of Mutation SubtypesKey Takeaways: For nearly 2 decades, identifying an EGFR mutation in non-small cell lung cancer (NSCLC) has been a "eureka" moment in...reactionscomments
Shared Decision Making in First-Line Therapy: Navigating the Trade-Off Between Survival Gains and Adverse EventsKey Takeaways: The therapeutic landscape for advanced non-small cell lung cancer (NSCLC) has shifted for many patients from a standardized chemotherapy approach...reactionscomments
Closing the Diagnostic Gap: Overcoming False Negatives via Integrated Liquid Biopsy and Reflex Next Generation SequencingKey Takeaways: In the era of precision oncology, the "wait and see" approach is no longer tenable for patients with advanced non-small...reactionscomments
HCPs: Test Your Lung Cancer KnowledgeWith the lung cancer treatment landscape shifting toward earlier intervention and increasingly specific targeted therapies, staying sharp is essential. This quiz skips...reactionscomments
Hear+Now: Managing the "Silent" Burden of Long-Term SurvivalIn this audio digest, we're diving into Health Union data surrounding long-term survival in patients with advanced lung cancer. Long-term survival for...reactionscomments
